Lou, Linjiang
Frishman, Laura J.
Beach, Krista M.
Rajagopalan, Lakshmi
Hung, Li-Fang
She, Zhihui
Smith, Earl L. III
Ostrin, Lisa A. http://orcid.org/0000-0001-8675-1478
Funding for this research was provided by:
National Eye Institute (R01 EY003611, P30 EY007551)
Brien Holden Vision Institute
Article History
Received: 24 December 2022
Accepted: 9 March 2023
First Online: 30 March 2023
Declarations
:
: ELS holds patents for optical and pharmaceutical treatment strategies for myopia and is a paid consultant for SightGlass Vision Inc., Treehouse Eyes Inc., and Vision CRC USA. The other authors declare that they have no conflict of interest.
: Study procedures were reviewed and approved by the Institutional Animal Care and Use Committee at the University of Houston.
: There are no human subjects in this study. We have included the ethics statements associated with animal studies.
: All procedures conformed to the ARVO statement for the Use of Animals in Ophthalmic and Vision Research.
: This article does not contain any studies with human participants performed by any of the authors.